2-55233469-A-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002954.6(RPS27A):c.103+52A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.759 in 1,341,404 control chromosomes in the GnomAD database, including 387,529 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.76 ( 44256 hom., cov: 32)
Exomes 𝑓: 0.76 ( 343273 hom. )
Consequence
RPS27A
NM_002954.6 intron
NM_002954.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.63
Genes affected
RPS27A (HGNC:10417): (ribosomal protein S27a) Ubiquitin, a highly conserved protein that has a major role in targeting cellular proteins for degradation by the 26S proteosome, is synthesized as a precursor protein consisting of either polyubiquitin chains or a single ubiquitin fused to an unrelated protein. This gene encodes a fusion protein consisting of ubiquitin at the N terminus and ribosomal protein S27a at the C terminus. When expressed in yeast, the protein is post-translationally processed, generating free ubiquitin monomer and ribosomal protein S27a. Ribosomal protein S27a is a component of the 40S subunit of the ribosome and belongs to the S27AE family of ribosomal proteins. It contains C4-type zinc finger domains and is located in the cytoplasm. Pseudogenes derived from this gene are present in the genome. As with ribosomal protein S27a, ribosomal protein L40 is also synthesized as a fusion protein with ubiquitin; similarly, ribosomal protein S30 is synthesized as a fusion protein with the ubiquitin-like protein fubi. Multiple alternatively spliced transcript variants that encode the same proteins have been identified.[provided by RefSeq, Sep 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 2-55233469-A-T is Benign according to our data. Variant chr2-55233469-A-T is described in ClinVar as [Benign]. Clinvar id is 1238560.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.768 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPS27A | NM_002954.6 | c.103+52A>T | intron_variant | Intron 3 of 5 | ENST00000272317.11 | NP_002945.1 | ||
RPS27A | NM_001135592.2 | c.103+52A>T | intron_variant | Intron 3 of 5 | NP_001129064.1 | |||
RPS27A | NM_001177413.1 | c.103+52A>T | intron_variant | Intron 2 of 4 | NP_001170884.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.761 AC: 115713AN: 151954Hom.: 44220 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
115713
AN:
151954
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.741 AC: 178080AN: 240220 AF XY: 0.740 show subpopulations
GnomAD2 exomes
AF:
AC:
178080
AN:
240220
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.758 AC: 902075AN: 1189332Hom.: 343273 Cov.: 16 AF XY: 0.757 AC XY: 457708AN XY: 604954 show subpopulations
GnomAD4 exome
AF:
AC:
902075
AN:
1189332
Hom.:
Cov.:
16
AF XY:
AC XY:
457708
AN XY:
604954
Gnomad4 AFR exome
AF:
AC:
21245
AN:
27930
Gnomad4 AMR exome
AF:
AC:
31249
AN:
43580
Gnomad4 ASJ exome
AF:
AC:
16157
AN:
24372
Gnomad4 EAS exome
AF:
AC:
23584
AN:
38168
Gnomad4 SAS exome
AF:
AC:
54678
AN:
80088
Gnomad4 FIN exome
AF:
AC:
44552
AN:
53018
Gnomad4 NFE exome
AF:
AC:
669895
AN:
867124
Gnomad4 Remaining exome
AF:
AC:
38167
AN:
51252
Heterozygous variant carriers
0
11428
22857
34285
45714
57142
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
14330
28660
42990
57320
71650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.761 AC: 115800AN: 152072Hom.: 44256 Cov.: 32 AF XY: 0.761 AC XY: 56552AN XY: 74322 show subpopulations
GnomAD4 genome
AF:
AC:
115800
AN:
152072
Hom.:
Cov.:
32
AF XY:
AC XY:
56552
AN XY:
74322
Gnomad4 AFR
AF:
AC:
0.764719
AN:
0.764719
Gnomad4 AMR
AF:
AC:
0.741364
AN:
0.741364
Gnomad4 ASJ
AF:
AC:
0.654755
AN:
0.654755
Gnomad4 EAS
AF:
AC:
0.627417
AN:
0.627417
Gnomad4 SAS
AF:
AC:
0.657949
AN:
0.657949
Gnomad4 FIN
AF:
AC:
0.844423
AN:
0.844423
Gnomad4 NFE
AF:
AC:
0.773173
AN:
0.773173
Gnomad4 OTH
AF:
AC:
0.762559
AN:
0.762559
Heterozygous variant carriers
0
1416
2832
4248
5664
7080
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
860
1720
2580
3440
4300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2320
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 14, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at